Lizhu Lin

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Wenfeng Fang, Yunpeng Yang, Yuxiang Ma et al. · The Lancet Oncology · 2018 · 507 citations

Medicine, Oncology, Pharmacology +13

Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)

Yunpeng Yang, Ting Zhou, Xiaozhong Chen et al. · Journal for ImmunoTherapy of Cancer · 2021 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues

Nong Yang, Yi Li, Zhidong Liu et al. · BMC Cancer · 2018 · 75 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Recent pharmacological advances in the repurposing of artemisinin drugs

Yuqing Meng, Nan Ma, Haining Lyu et al. · Medicinal Research Reviews · 2021 · 48 citations

Medicine, Medicinal Chemistry, Pharmacology +17

An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer

Jue Zhang, Zhipeng Qu, Hong Yao et al. · Biomedicine & Pharmacotherapy · 2019 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17